A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group

Humaid O Al-Shamsi 1 2 3, Waleed Alhazzani 4 5, Ahmad Alhuraiji 6, Eric A Coomes 7, Roy F Chemaly 8, Meshari Almuhanna 9, Robert A Wolff 10, Nuhad K Ibrahim 11, Melvin L K Chua 12 13 14, Sebastien J Hotte 15, Brandon M Meyers 15, Tarek Elfiki 16 17, Giuseppe Curigliano 18 19 20 21, Cathy Eng 22, Axel Grothey 23, Conghua Xie 24


 

Affiliations

01 June 2020

-

doi: 10.1634/theoncologist.2020-0213

Abstract

The outbreak of coronavirus disease 2019 (COVID-19) has rapidly spread globally since being identified as a public health emergency of major international concern and has now been declared a pandemic by the World Health Organization (WHO). In December 2019, an outbreak of atypical pneumonia, known as COVID-19, was identified in Wuhan, China. The newly identified zoonotic coronavirus, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is characterized by rapid human-to-human transmission. Many cancer patients frequently visit the hospital for treatment and disease surveillance. They may be immunocompromised due to the underlying malignancy or anticancer therapy and are at higher risk of developing infections. Several factors increase the risk of infection, and cancer patients commonly have multiple risk factors. Cancer patients appear to have an estimated twofold increased risk of contracting SARS-CoV-2 than the general population. With the WHO declaring the novel coronavirus outbreak a pandemic, there is an urgent need to address the impact of such a pandemic on cancer patients. This include changes to resource allocation, clinical care, and the consent process during a pandemic. Currently and due to limited data, there are no international guidelines to address the management of cancer patients in any infectious pandemic. In this review, the potential challenges associated with managing cancer patients during the COVID-19 infection pandemic will be addressed, with suggestions of some practical approaches. IMPLICATIONS FOR PRACTICE: The main management strategies for treating cancer patients during the COVID-19 epidemic include clear communication and education about hand hygiene, infection control measures, high-risk exposure, and the signs and symptoms of COVID-19. Consideration of risk and benefit for active intervention in the cancer population must be individualized. Postponing elective surgery or adjuvant chemotherapy for cancer patients with low risk of progression should be considered on a case-by-case basis. Minimizing outpatient visits can help to mitigate exposure and possible further transmission. Telemedicine may be used to support patients to minimize number of visits and risk of exposure. More research is needed to better understand SARS-CoV-2 virology and epidemiology.

Keywords: COVID-19; Coronavirus; Influenza; Neoplasm; Pandemic; SARS-CoV-2.

Conflict of interest statement

Disclosures of potential conflicts of interest may be found at the end of this article.

References

  1.  
    1. Worldometer . COVID‐19 Coronovirus Pandemic. Available at https://www.worldometers.info/coronavirus/#countries. Accessed March 16, 2020.
  2.  
    1. Guan WJ, Ni ZY, Hu Y et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020. [Epub ahead of print].
  3.  
    1. Yu J, Ouyang W, Chua MLK et al. SARS‐CoV‐2 transmission in cancer patients of a tertiary hospital in Wuhan. JAMA Oncol 2020 [Epub ahead of print].
  4.  
    1. World Health Organization . WHO Director‐General's opening remarks at the media briefing on COVID‐19, March 11, 2020. Available at https://www.who.int/dg/speeches/detail/who‐director‐general‐s‐opening‐re.... Accessed March 11, 2020.
  5.  
    1. Anderson RM, Heesterbeek H, Klinkenberg D et al. How will country‐based mitigation measures influence the course of the COVID‐19 epidemic? Lancet 2020;395:931–934. - PMC - PubMed
  6.  
    1. World Health Organization . Coronavirus disease (COVID‐19) Pandemic. Available at https://www.who.int/emergencies/diseases/novel‐coronavirus‐2019. Accessed March 11, 2020.
  7.  
    1. Liang W, Guan W, Chen R et al. Cancer patients in SARS‐CoV‐2 infection: A nationwide analysis in China. Lancet Oncol 2020;21:335–337. - PMC - PubMed
  8.  
    1. Dignani MC, Costantini P, Salgueira C et al. Pandemic 2009 influenza A (H1N1) virus infection in cancer and hematopoietic stem cell transplant recipients; a multicenter observational study. F1000Res 2014;3:221. - PMC - PubMed
  9.  
    1. Battershill PM. Influenza pandemic planning for cancer patients. Curr Oncol 2006;13:119–120. - PMC - PubMed
  10.  
    1. ASCO COVID‐19 Clinical Oncology Frequently Asked Questions (FAQs). Last updated – March 12, 2020. Available at https://www.asco.org/sites/new‐www.asco.org/files/content‐files/blog‐rel.... Accessed March 14, 2020.
  11.  
    1. World Health Organization. Disease outbreak news: Novel coronavirus – Republic of Korea (ex‐China). January 21, 2020. Available at https://www.Who.Int/csr/don/21‐january‐2020‐novel‐coronavirus‐republic‐o.... Accessed January 21, 2020.
  12.  
    1. Centers for Disease Control and Prevention. Coronavirus Disease 2019 (COVID‐19). Cases in the U.S. Available at https://www.cdc.gov/coronavirus/2019-ncov/cases-in-us.html. Accessed March 10, 2020).
  13.  
    1. Lu R, Zhao X, Li J et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. Lancet 2020;395:565–574. - PMC - PubMed
  14.  
    1. Perlman S. Another decade, another coronavirus. N Engl J Med 2020;382:760–762. - PMC - PubMed
  15.  
    1. Li Q, Guan X, Wu P et al. Early transmission dynamics in Wuhan, China, of novel coronavirus‐infected pneumonia. N Engl J Med 2020;382:1199–1207. - PMC - PubMed
  16.  
    1. Chan JF, Yuan S, Kok KH et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person‐to‐person transmission: A study of a family cluster. Lancet 2020;395:514–523. - PMC - PubMed
  17.  
    1. Novel Coronavirus Pneumonia Emergency Response Epidemiology Team . The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID‐19) in China [in Chinese]. Zhonghua Liu Xing Bing Xue Za Zhi 020;41:145–151. - PubMed
  18.  
    1. Report of the WHO–China Joint Mission on Coronavirus Disease 2019 (COVID‐19). Available at https://www.Who.Int/docs/default‐source/coronaviruse/who‐china‐joint‐mis.... Accessed March 12, 2020.
  19.  
    1. Onder G, Rezza G, Brusaferro S. Case‐fatality rate and characteristics of patients dying in relation to COVID‐19 in Italy. JAMA 2020. [Epub ahead of print]. - PubMed
  20.  
    1. Willan J, King AJ, Hayes S et al. Care of haematology patients in a COVID‐19 epidemic. Br J Haematol 2020. [Epub ahead of print]. - PMC - PubMed
  21.  
    1. The Cancer Letter . What to expect: Oncology's response to coronavirus in Italy: “It's like being in a war”. Available at https://cancerletter.Com/articles/20200311_1/. Accessed March 13, 2020.
  22.  
    1. Mukherjee RK, Back MF, Lu JJ et al. Hiding in the bunker: Challenges for a radiation oncology department operating in the severe acute respiratory syndrome outbreak. Australas Radiol 2003;47:143–145. - PubMed
  23.  
    1. Hospitals are canceling elective surgeries to make space for a potential flood of coronavirus patients. Available at https://www.cnbc.com/2020/03/13/hospitals‐cancel‐elective‐surgery‐to‐mak.... Accessed March 20, 2020.
  24.  
    1. Alpert A, Jacobson M. Impact of oncology drug shortages on chemotherapy treatment. Clin Pharmacol Ther 2019;106:415–421. - PMC - PubMed
  25.  
    1. U.S. Food & Drug Administration . FDA statement: Coronavirus (COVID‐19) supply chain update. Available at https://www.fda.gov/news‐events/press‐announcements/coronavirus‐covid‐19.... Accessed March 20, 2020.
  26.  
    1. U.S. Food & Drug Administration . FDA drug shortages. Available at https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm. Accessed March 21, 2020.
  27.  
    1. Vox . Could the coronavirus spark drug shortages in the US? Available at https://www.vox.com/2020/3/9/21163356/coronavirus‐drug‐shortage‐potentia.... Accessed March 20, 2020.
  28.  
    1. Ventola CL. The drug shortage crisis in the United States: Causes, impact, and management strategies. P T 2011;36:740–757. - PMC - PubMed
  29.  
    1. Repici A, Maselli R, Colombo M et al. Coronavirus (COVID‐19) outbreak: What the department of endoscopy should know. Gastrointest Endosc 2020. [Epub ahead of print]. - PMC - PubMed
  30.  
    1. Chen YM, Perng RP, Chu H et al. Impact of severe acute respiratory syndrome on the status of lung cancer chemotherapy patients and a correlation of the signs and symptoms. Lung Cancer 2004;45:39–43. - PMC - PubMed
  31.  
    1. CBC News . 14 cancer patients at Hamilton hospital saw doctor who tested positive for COVID‐19. Available at https://www.cbc.ca/news/canada/hamilton/covid19-first-case-doctor-hamilt.... Accessed March 12, 2020.
  32.  
    1. Nishiura H, Kobayashi T, Suzuki A et al. Estimation of the asymptomatic ratio of novel coronavirus infections (COVID‐19). Int J Infect Dis 2020. [Epub ahead of print]. - PMC - PubMed
  33.  
    1. Mizumoto K, Kagaya K, Zarebski A et al. Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID‐19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Euro Surveill 2020;25:pii=2000180. - PMC - PubMed
  34.  
    1. Steinkuller F, Harris K, Vigil KJ et al. Outpatient infection prevention: A practical primer. Open Forum Infect Dis 2018;5:ofy053. - PMC - PubMed
  35.  
    1. World Health rganization . Coronavirus disease (2019‐COVID‐19) technical guidance: Patient management. Available at https://www.who.int/emergencies/diseases/novel‐coronavirus‐2019/technica.... Accessed March 4, 2020.
  36.  
    1. Tablan OC, Anderson LJ, Besser R et al. Guidelines for preventing health‐care‐associated pneumonia, 2003: Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep 2004;53:1–36. - PubMed
  37.  
    1. Centers for Disease Contro and Prevention . Interim infection prevention and control recommendations for patients with suspected or confirmed coronavirus disease 2019 (COVID‐19) in healthcare settings. Available at https://www.cdc.gov/coronavirus/2019‐ncov/infection‐control/control‐reco.... Accessed March 6, 2020.
  38.  
    1. Hofheinz RD, Wenz F, Post S et al. Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: A randomised, multicentre, non‐inferiority, phase 3 trial. Lancet Oncol 2012;13:579–588. - PubMed
  39.  
    1. Zou XC, Wang QW, Zhang JM. Comparison of 5‐fu‐based and capecitabine‐based neoadjuvant chemoradiotherapy in patients with rectal cancer: A meta‐analysis. Clin Colorectal Cancer 2017;16:e123–e139. - PubMed
  40.  
    1. Shereen NG, Salman D. Delivering chemotherapy at home: How much do we know? Br nursing Community Nurs 2019;24:482–484. - PubMed
  41.  
    1. Warr J, Hird AE, DeAngelis C et al. Baseline blood work before initiation of chemotherapy: What is safe in the real world? J Oncol Pract 2013;9:e182–185. - PubMed
  42.  
    1. The New York Times . Doctors and patients turn to telemedicine in the coronavirus outbreak. Available at https://www.nytimes.com/2020/03/11/health/telemedicine‐coronavirus.html. Accessed March 12, 2020.
  43.  
    1. Sirintrapun SJ, Lopez AM. Telemedicine in cancer care. Am Soc Clin Oncol Educ Book 2018;38:540–545. - PubMed
  44.  
    1. van Doremalen N, Bushmaker T, Morris DH et al. Aerosol and surface stability of SARS‐CoV‐2 as compared with SARS‐CoV‐1. N Engl J Med 2020 [Epub ahead of print]. - PMC - PubMed
  45.  
    1. ASTRO . COVID‐19 recommendations to radiation oncology practices. Available at https://www.astro.org/daily-practice/covid-19-recommendations-and-inform.... Accessed March 20, 2020.
  46.  
    1. Numico G, Cristofano A, Mozzicafreddo A et al. Hospital admission of cancer patients: Avoidable practice or necessary care? PLoS One 2015;10:e0120827. - PMC - PubMed
  47.  
    1. Stukel TA, Schull MJ, Guttmann A et al. Health impact of hospital restrictions on seriously ill hospitalized patients: Lessons from the Toronto SARS outbreak. Med Care 2008;46:991–997. - PubMed
  48.  
    1. European Centre for Disease Prevention and Control . Outbreak of novel coronavirus disease 2019 (COVID‐19): Increased transmission globally – fifth update. Available at https://www.ecdc.europa.eu/en/publications‐data/rapid‐risk‐assessment‐ou.... Accessed March 6, 2020.
  49.  
    1. Adams JG, Walls RM. Supporting the health care workforce during the COVID‐19 global epidemic. JAMA 2020. [Epub ahead of print]. - PubMed
  50.  
    1. Bos AC, van Erning FN, van Gestel YR et al. Timing of adjuvant chemotherapy and its relation to survival among patients with stage iii colon cancer. Eur J Cancer 2015;51:2553–2561. - PubMed
  51.  
    1. American College of Surgeons . Recommendations for prioritization, treatment and triage of breast cancer patients during the COVID‐19 pandemic. Available at https://www.facs.org/quality-programs/cancer/executive-summary. Accessed March 26, 2020.
  52.  
    1. Centers for Disease Control And Prevention . Interim clinical guidance for management of patients with confirmed coronavirus disease (COVID‐19). Available at https://www.cdc.gov/coronavirus/2019‐ncov/hcp/clinical‐guidance‐manageme.... Accessed March 4, 2020.
  53.  
    1. Mansfield SA, Abdel‐Rasoul M, Terando AM et al. Timing of breast cancer surgery‐how much does it matter? Breast J 2017;23:444–451. - PubMed
  54.  
    1. American College of Surgeons . COVID‐19: Guidance for triage of non‐emergent surgical procedures. Available at https://www.facs.org/about‐acs/covid‐19/information‐for‐surgeons/triage. Accessed March 20, 2020.
  55.  
    1. Feng RM, Zong YN, Cao SM et al. Current cancer situation in china: Good or bad news from the 2018 global cancer statistics? Cancer Commun (Lond) 2019;39:22. - PMC - PubMed
  56.  
    1. Yang L, Xu HY, Wang Y. Diagnostic and therapeutic strategies of lung cancer patients during the outbreak of 2019 novel coronavirus disease (COVID‐19) [in Chinese]. Zhonghua Zhong Liu Za Zhi 2020;42:E006. - PubMed
  57.  
    1. Ohrmalm L, Wong M, Rotzen‐Ostlund M et al. Flocked nasal swab versus nasopharyngeal aspirate for detection of respiratory tract viruses in immunocompromised adults: A matched comparative study. BMC Infect Dis 2010;10:340. - PMC - PubMed
  58.  
    1. Sim SA, Leung VKY, Ritchie D et al. Viral respiratory tract infections in allogeneic hematopoietic stem cell transplantation recipients in the era of molecular testing. Biol Blood Marrow Transplant 2018;24:1490–1496. - PMC - PubMed
  59.  
    1. Lee I, Barton TD. Viral respiratory tract infections in transplant patients: Epidemiology, recognition and management. Drugs 2007;67:1411–1427. - PMC - PubMed
  60.  
    1. Hirsch HH, Martino R, Ward KN et al. Fourth European Conference on Infections in Leukaemia (ECIL‐4): Guidelines for diagnosis and treatment of human respiratory syncytial virus, parainfluenza virus, metapneumovirus, rhinovirus, and coronavirus. Clin Infect Dis 2013;56:258–266. - PMC - PubMed
  61.  
    1. Chemaly RF, Shah DP, Boeckh MJ. Management of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignancies. Clin Infect Dis 2014;59 Suppl 5:S344–S351. - PMC - PubMed
  62.  
    1. Whimbey E, Champlin RE, Couch RB et al. Community respiratory virus infections among hospitalized adult bone marrow transplant recipients. Clin Infect Dis 1996;22:778–782. - PubMed
  63.  
    1. Dignan FL, Clark A, Aitken C et al. BCSH/BSBMT/UK clinical virology network guideline: Diagnosis and management of common respiratory viral infections in patients undergoing treatment for haematological malignancies or stem cell transplantation. Br J Haematol 2016;173:380–393. - PMC - PubMed
  64.  
    1. Blaschke AJ, Allison MA, Meyers L et al. Non‐invasive sample collection for respiratory virus testing by multiplex PCR. J Clin Virol 2011;52:210–214. - PMC - PubMed
  65.  
    1. Campbell AP, Guthrie KA, Englund JA et al. Clinical outcomes associated with respiratory virus detection before allogeneic hematopoietic stem cell transplant. Clin Infect Dis 2015;61:192–202. - PMC - PubMed
  66.  
    1. EBMT . Coronavirus disease COVID‐19: EBMT recommendations. Available at https://www.ebmt.org/ebmt/news/ebmt‐recommendation‐coronavirus‐disease‐c.... Accessed March 5, 2020.
  67.  
    1. U.S. Food & Drug Administration . Coronavirus (COVID‐19) update: Blood donations. Available at https://www.fda.gov/news‐events/press‐announcements/coronavirus‐covid‐19.... Accessed March 20, 2020.
  68.  
    1. World Health Organization . Maintaining a safe and adequate blood supply during pandemic influenza guidelines for blood transfusion services, July 2011. Available at https://www.who.int/bloodsafety/transfusion_services/WHO_Guidelines_on_P.... Accessed March 16, 2020.
  69.  
    1. https://twitter.com/itsnot_pink/status/1238590023571832834. Accessed March 15, 2020.
  70.  
    1. https://twitter.com/mattgalsky/status/1238933344135544833. Accessed March 15, 2020.
  71.  
    1. Busta ER, Mancher M, Cuff PA et al. Integrating clinical research into epidemic response: The Ebola experience. National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Sciences Policy; Board on Global Health; Committee on Clinical Trials During the 2014–2015 Ebola Outbreak. Washington (DC): National Academies Press (US); 2017. June.
  72.  
    1. FDA guidance on conduct of clinical trials of medical products during COVID‐19 pandemic, guidance for industry, investigators, and institutional review boards. Available at https://www.fda.gov/media/136238/download. Accessed March 20, 2020.
  73.  
    1. The Medical Journal of Australia . Managing haematology and oncology patients during the COVID‐19 pandemic: Interim consensus guidance. Available at https://www.mja.com.au/journal/2020/212/10/managing‐haematology‐and‐onco.... Accessed March 26, 2020. - PMC - PubMed
  74.  
    1. Clinical guide for the management of cancer patients during the coronavirus pandemic, 17 March 2020, version 1, Available at https://www.england.nhs.uk/coronavirus/wp‐content/uploads/sites/52/2020/.... Accessed March 17, 2020.

Page Navigation